The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare telehealth access and programs like SNAP.| MedCity News
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue.| MedCity News
Leaders from the VA and the ONC discussed how the future of U.S. healthcare will rely on both technology and creative problem-solving during a panel at DiMe’s Healthcare 2030 Summit.| MedCity News
A federal judge in Texas recently ruled on medical debt reporting — here's what the ruling means for providers and for the millions of Americans who currently have or might one day have medical debt.| MedCity News
